CRL-40,941 is a molecule similar to moda finil and adrafinil and has shown that it is more effective than these two molecules in their indications with fewer side effects. It is a wakefulness-promoting agent used for treatment of disorders such as narcolepsy, shift work sleep disorder, and excessive daytime sleepiness associated with obstructive sleep apnea. Finally, it will be to positively modulate Glutamate receptors as well which is theorized to be the main mechanism of action behind the cognitive benefits of this smart drug.
The drug is reported to have little or no side effects when taken at the correct dose over a short period of time. Fladrafinil is only designed and intended for short term use. Long-term use and misuse of the drug can affect our brain in many ways.
This medicine blocks the reuptake of dopamine and norepinephrine in the presynaptic cleft immediately upon being released. Long-term use of the drug causes lesions on cerebral blood pathways and brain injury affects the efficiency of neurotransmitter substances in our brain.
